Nephrologists Transforming Dialysis Safety

Welcome to the Nephrologists Transforming Dialysis Safety ASN Community Website.  You will need to Sign In to access the Community discussions and resources.

  • If you have an user name and password, select  the "Sign In" button in the top right corner of this page. 
  • If you do not have a free user name and password, you can get one from  Once you have your free registration, you will be redirected to this site and you can Sign In with your new user name and password.  

Latest Discussion Posts

Please login to see all eligible discussion postings

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.

Community Minded

Rituximab refractory PLA2R positive membranous glomerulonephritis
A 53-year-old man who has nephrotic syndrome (12 grams) and multiple thromboses and a PLA2R level >1500 receives two 1 gram doses of rituximab. Four months later his PLA2R is down to 800 but his proteinuria is unchanged. By six months his PLA2r is back to >1500 and his proteinuria is now 21 grams. What would you do next? Share your thoughts.

Summary provided by Roger Rodby, MD, FASN.
Previous Community Minded Summaries are available at: 

Community Leaders